1. The Rise of “Cardio-Metabolic” Medicine The GLP-1 Revolution: Beyond weight loss, discuss how semaglutide and tirzepatide are becoming staple cardiology prescriptions to reduce heart attack and stroke risk by up to 20%. Targeting Chronic Inflammation: Focus on high-sensitivity C-reactive protein (hs-CRP) as a primary metric for heart health, moving the conversation from just “cholesterol” […]